WC
EHC icon

Wexford Capital’s Encompass Health EHC Stock Holding History

Wexford Capital’s Portfolio EHC Stock Details EHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-24,523
Closed -$1.6M – 177
2021
Q1 		$1.6M Buy
+24,523
New +$1.6M 0.24% 94
2020
Q4 		– Sell
-8,648
Closed -$447K – 325
2020
Q3 		$447K Sell
8,648
-131,152
-94% -$6.73M 0.12% 93
2020
Q2 		$6.89M Buy
139,800
+87,066
+165% +$4.7M 1.73% 21
2020
Q1 		$2.69M Sell
52,734
-30,252
-36% -$1.74M 0.99% 35
2019
Q4 		$4.57M Buy
+82,986
New +$4.5M 0.7% 45
2013
Q3 		– Sell
-43,995
Closed -$1.01M – 220
2013
Q2 		$1.01M Buy
+43,995
New +$994K 0.09% 116

Other funds holding EHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP
Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wexford Capital's EHC Position: Q2 2021 in Review

Wexford Capital sold out of Encompass Health (EHC) in Q2 2021, closing a stake of 24,523 shares — an estimated $1.6M sold.

Wexford Capital first reported a position in EHC in Q2 2013 and held it in 6 quarters. The position peaked at $6.89M in Q2 2020. 414 funds tracked by Wall St. Rank hold EHC as of Q2 2021.

  • Wexford Capital reported no remaining Encompass Health position as of Q2 2021 after selling out during the quarter.
  • Wexford Capital sold 24,523 Encompass Health shares in Q2 2021, an estimated $1.6M.
  • Wexford Capital first reported a position in Encompass Health in Q2 2013 and held it in 6 quarters.
  • Wexford Capital's Encompass Health position peaked at $6.89M in Q2 2020.
  • 414 funds tracked by Wall St. Rank held Encompass Health as of Q2 2021.

Based on Wexford Capital's 13F filing for Q2 2021, filed 16 Aug 2021.